(a) and (b) Time series of weekly aggregates of norovirus GII RNA concentrations (filled shapes with solid lines), detection frequency (open shapes with dashed lines), and national... by Jay C. Bullen (10232606)

<i>In situ</i> hybridization of <i>Ramp2</i> in e13.5 placentas reveals robust expression in the labyrinth layer. by Mahita Kadmiel (4262311)

Comparison of the ratio of the early diastolic filling velocity to the late diastolic filling velocity (E/A ratio) in 139 lowlanders at the altitudes of 500 m, 3700 m and 4400 m. by Mingyue Rao (687325)

Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs by Lindsey Burggraaff (6243110)

“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”

Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs by Lindsey Burggraaff (6243110)

“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”

Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs by Lindsey Burggraaff (6243110)

“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”

Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs by Lindsey Burggraaff (6243110)

“…Endogenous ligands, such as hormones and neurotransmitters, bind to the orthosteric site, while synthetic ligands may bind to orthosteric or allosteric sites, which has become a focal point in drug discovery. Usually, such allosteric modulators bind to a protein noncompetitively with its endogenous ligand or substrate. …”

Data_Sheet_1_Hsa-miR-100-3p Controls the Proliferation, DNA Synthesis, and Apoptosis of Human Sertoli Cells by Binding to SGK3.CSV by Bang Liu (48169)

“…We revealed that miR-100-3p was expressed at a higher level in human Sertoli cells by 10% fetal bovine serum (FBS) than 0.5% FBS. …”

Results of parameter estimation and comparison. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Distribution of nod lengths. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Terminology used in this study. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

MAEs of each window size. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Screenshot of the corpus. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Posterior distribution of fixed effects. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Sox2 is upstream of <i>Atoh1</i> and <i>Huwe1</i> in embryonic development and <i>Huwe1</i> knockdown results in hair cell generation from dividing supporting cells. by Yen-Fu Cheng (5819855)

Income-related inequalities in diabetes by sex, age, and race/ethnicity among US adults aged ≥ 18 years, 2001–2018. by Yu Chen (29959)

The staining percentages of TLR1-TLR10 in epithelial layers, basement membrane (BM) zone, endothelium and in the infiltrative zone. by Peter Rusanen (4252870)

The effect of cPTIO pre-treatment on cell death rate. by Bushra Ijaz (4353385)

“…<p>Cell death rate as measured in tolerant (a) and sensitive (b) cell cultures after 50uM cPTIO pre-treatment and 100 and 150mM NaCl stress. …”